NOVT logo

Novanta Inc. Stock Price

NasdaqGS:NOVT Community·US$3.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author

NOVT Share Price Performance

US$102.70
-72.28 (-41.31%)
27.4% undervalued intrinsic discount
US$141.50
Fair Value
US$102.70
-72.28 (-41.31%)
27.4% undervalued intrinsic discount
US$141.50
Fair Value
Price US$102.70
AnalystConsensusTarget US$141.50

NOVT Community Narratives

AnalystConsensusTarget·
Fair Value US$141.5 27.4% undervalued intrinsic discount

Robotics And Healthcare Demand Will Expand Market Opportunities

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent NOVT News & Updates

Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?

Oct 07
Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta: The Solution To Elevated Expectations Is Lower Prices

Sep 29

Novanta's (NASDAQ:NOVT) Returns Have Hit A Wall

Sep 13
Novanta's (NASDAQ:NOVT) Returns Have Hit A Wall

Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor Opinion

Aug 29
Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor Opinion

Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?

Jun 16
Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?

Novanta Inc. Key Details

US$956.9m

Revenue

US$525.6m

Cost of Revenue

US$431.3m

Gross Profit

US$370.0m

Other Expenses

US$61.4m

Earnings

Last Reported Earnings
Jun 27, 2025
Next Reporting Earnings
Nov 04, 2025
Earnings per share (EPS)
1.71
Gross Margin
45.08%
Net Profit Margin
6.41%
Debt/Equity Ratio
57.3%

Novanta Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Moderate growth potential with mediocre balance sheet.

2 Risks
1 Reward

About NOVT

Founded
1968
Employees
3000
CEO
Matthijs Glastra
WebsiteView website
www.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.8%
  • 3 Months: 8.3%
  • 1 Year: 17.8%
  • Year to Date: 15.4%
Over the last 7 days, the market has remained flat, although notably the Utilities sector gained 3.1% in that time. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›